M&A

For an Aggregate of $1.8B, Biogen Acquires Human Immunology Biosciences to Strengthen its Immunology Portfolio

For an Aggregate of $1.8B, Biogen Acquires Human Immunology Biosciences to Strengthen its Immunology Portfolio

Shots: Biogen acquiring HI-Bio to advance felzartamab & HI-Bio’s pipelin...

Swixx Biopharma Acquires Biopas, Expanding its Presence to Latin America

Swixx Biopharma Acquires Biopas, Expanding its Presence to Latin America

Shots: Swixx BioPharma has agreed to acquire 100% of Pharma Consulting Group&rsquo...

Johnson & Johnson to Expand its Dermatology Portfolio Through the Acquisition of Proteologix

Johnson & Johnson to Expand its Dermatology Portfolio Through the Acquisition of Proteologix

Shots: Johnson & Johnson has agreed to acquire Proteologix to expand its derma...

Arbor Biotechnologies to Acquire Serendipity Biosciences

Arbor Biotechnologies to Acquire Serendipity Biosciences

Shots: Arbor Biotechnologies has agreed to acquire Serendipity Biosciences, enhanc...

Catalent's Acquisition by Novo Holdings Put on Hold for 30 Days for Antitrust Review

Catalent's Acquisition by Novo Holdings Put on Hold for 30 Days for Antitrust Review

Shots: According to the acquisition, Catalent will receive a $16.5B all-cash payme...

Novartis to Acquire Mariana Oncology, Expanding its Radioligand Therapy Pipeline

Novartis to Acquire Mariana Oncology, Expanding its Radioligand Therapy Pipeline

Shots: Novartis has agreed to acquire Mariana Oncology to strengthen its radioliga...

Image